During the past decade, KEMRI CRDR Clinical Research Clinic Nairobi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "KEMRI CRDR Clinical Research Clinic Nairobi" are "Sickle Cell Disease" (3 trials), "Vaso-occlusive Crisis" (2 trials), "Vaso-occlusive Pain Episode in Sickle Cell Disease" (2 trials) and "Leg Ulcers" (1 trials). Many other conditions were trialed in "KEMRI CRDR Clinical Research Clinic Nairobi" in a lesser frequency.

Most popular intervention types in "KEMRI CRDR Clinical Research Clinic Nairobi" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Inclacumab" (2 trials) and "Voxelotor Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "KEMRI CRDR Clinical Research Clinic Nairobi" are 3 trials for "All" genders.

Currently, there are NaN active trials in "KEMRI CRDR Clinical Research Clinic Nairobi". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in KEMRI CRDR Clinical Research Clinic Nairobi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in KEMRI CRDR Clinical Research Clinic Nairobi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".